7.0.0.0 Ref­er­ences

1. Pow­ers MA, Bard­s­ley J, Cy­press M, et al. Di­a­betes self-‍man­age­ment ed­u­ca­tion and sup­port in type 2 di­a­betes: a joint po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion, the Amer­i­can As­so­ci­a­tion of Di­a­betes Ed­u­ca­tors, and the Acade­my of Nu­tri­tion and Di­etet­ics. Di­a­betes Care 2015;38:1372–1382
2. Dick­in­son JK, Guz­man SJ, Maryniuk MD, et al. The use of lan­guage in di­a­betes care and ed­u­ca­tion. Di­a­betes Care 2017;40:1790–1799
3. Dick­in­son JK, Maryniuk MD. Build­ing ther­a­peu­tic re­la­tion­ships: choos­ing words that put peo­ple first. Clin Di­a­betes 2017;35:51–54
4. Beck J, Green­wood DA, Blan­ton L, et al.; 2017 Stan­dards Revi­sion Task Force. 2017 na­tion­al stan­dards for di­a­betes self-‍man­age­ment ed­u­ca­tion and sup­port. Di­a­betes Care 2017;40:1409– 1419
5. Tang TS, Fun­nell MM, Brown MB, Kur­lan­der JE. Self-‍man­age­ment sup­port in “real-‍world” set­tings: an em­pow­er­ment-‍based in­ter­ven­tion. Pa­tient Educ Couns 2010;79:178–184
6. Mar­rero DG, Ard J, De­la­mater AM, et al. Twenty-‍first cen­tu­ry be­hav­ioral medicine: a con­text for em­pow­er­ing clin­i­cians and pa­tients with di­a­betes: a con­sen­sus re­port. Di­a­betes Care 2013;36:463–470
7. Nor­ris SL, Lau J, Smith SJ, Schmid CH, En­gel­gau MM. Self-‍man­age­ment ed­u­ca­tion for adults with type 2 di­a­betes: a meta-‍anal­y­sis of the ef­fect on glycemic con­trol. Di­a­betes Care 2002; 25:1159–1171
8. Haas L, Maryniuk M, Beck J, et al.; 2012 Stan­dards Revi­sion Task Force. Na­tion­al stan­dards for di­a­betes self-‍man­age­ment ed­u­ca­tion and sup­port. Di­a­betes Care 2014;37(Suppl. 1): S144–S153
9. Frosch DL, Uy V, Ochoa S, Man­gione CM. Eval­u­a­tion of a be­hav­ior sup­port in­ter­ven­tion for pa­tients with poor­ly con­trolled di­a­betes. Arch In­tern Med 2011;171:2011–2017
10. Cooke D, Bond R, Law­ton J, et al.; U.K. NIHR DAFNE Study Group. Struc­tured type 1 di­a­betes ed­u­ca­tion de­liv­ered with­in rou­tine care: im­pact on glycemic con­trol and di­a­betes-‍specific qual­i­ty of life. Di­a­betes Care 2013;36:270– 272
11. Chrvala CA, Sherr D, Lip­man RD. Di­a­betes self-‍man­age­ment ed­u­ca­tion for adults with type 2 di­a­betes mel­li­tus: a sys­tematic re­view of the ef­fect on glycemic con­trol. Pa­tient Educ Couns 2016;99:926–943
12. Steins­bekk A, Rygg LØ, Lisu­lo M, Rise MB, Fretheim A. Group based di­a­betes self-‍man­age­ment ed­u­ca­tion com­pared to rou­tine treat­ment for peo­ple with type 2 di­a­betes mel­li­tus. A sys­tematic re­view with meta-‍anal­y­sis. BMC Health Serv Res 2012;12:213
13. Deakin T, Mc­Shane CE, Cade JE, Williams RD. Group based train­ing for self-‍man­age­ment strate­gies in peo­ple with type 2 di­a­betes mel­li­tus. Cochrane Database Syst Rev 2005;2: CD003417
14. Cochran J, Conn VS. Meta-‍anal­y­sis of qual­i­ty of life out­comes fol­lowing di­a­betes self-‍man­age­ment train­ing. Di­a­betes Educ 2008;34: 815–823
15. He X, Li J, Wang B, et al. Di­a­betes self-‍man­age­ment ed­u­ca­tion re­duces risk of all-‍cause mor­tal­i­ty in type 2 di­a­betes pa­tients: a sys­tematic re­view and meta-‍anal­y­sis. En­docrine 2017; 55:712–731
16. Thor­pe CT, Fahey LE, John­son H, Desh­pande M, Thor­pe JM, Fish­er EB. Fa­cil­i­tat­ing healthy cop­ing in pa­tients with di­a­betes: a sys­tematic re­view. Di­a­betes Educ 2013;39:33–52
17. Fish­er L, Hessler D, Glas­gow RE, et al. RE­DEEM: a prag­mat­ic trial to re­duce di­a­betes dis­tress. Di­a­betes Care 2013;36:2551–2558
18. Rob­bins JM, Thatch­er GE, Webb DA, Vald­ma­n­is VG. Nu­tri­tionist vis­its, di­a­betes class­es, and hos­pi­talization rates and charges: the Urban Di­a­betes Study. Di­a­betes Care 2008;31: 655–660
19. Dun­can I, Ahmed T, Li QE, et al. As­sess­ing the value of the di­a­betes ed­u­ca­tor. Di­a­betes Educ 2011;37:638–657
20. Straw­bridge LM, Lloyd JT, Mead­ow A, Riley GF, How­ell BL. One-‍year out­comes of di­a­betes self-‍man­age­ment train­ing among Medi­care beneficia­ries newly di­ag­nosed with di­a­betes. Med Care 2017;55:391–397
21. Piatt GA, An­der­son RM, Brooks MM, et al. 3-year fol­low-‍up of clin­i­cal and be­hav­ioral im­provements fol­lowing a mul­ti­faceted di­a­betes care in­ter­ven­tion: re­sults of a ran­dom­ized con­trolled trial. Di­a­betes Educ 2010;36:301–309
22. Glazier RH, Ba­j­car J, Ken­nie NR, Will­son K. A sys­tematic re­view of in­ter­ven­tions to im­prove di­a­betes care in so­cially dis­ad­van­taged pop­u­la­tions. Di­a­betes Care 2006;29:1675–1688
23. Hawthorne K, Rob­les Y, Cannings-‍John R, Ed­wards AG. Cul­tu­ral­ly ap­pro­pri­ate health ed­u­ca­tion for type 2 di­a­betes mel­li­tus in eth­nic mi­nor­i­ty groups. Cochrane Database Syst Rev 2008;3:CD006424
24. Cho­dosh J, Mor­ton SC, Mo­ji­ca W, et al. Meta­anal­y­sis: chron­ic dis­ease self-‍man­age­ment pro­grams for older adults. Ann In­tern Med 2005; 143:427–438
25. Sark­isian CA, Brown AF, Nor­ris KC, Wintz RL, Man­gione CM. A sys­tematic re­view of di­a­betes self-‍care in­ter­ven­tions for older, African Amer­i­can, or Lati­no adults. Di­a­betes Educ 2003;29: 467–479
26. Pey­rot M, Rubin RR. Be­hav­ioral and psy­choso­cial in­ter­ven­tions in di­a­betes: a con­cep­tu­al re­view. Di­a­betes Care 2007;30:2433–2440
27. Naik AD, Palmer N, Pe­tersen NJ, et al. Com­par­a­tive ef­fectiveness of goal set­ting in di­a­betes mel­li­tus group clin­ics: ran­dom­ized clin­i­cal trial. Arch In­tern Med 2011;171:453–459
28. Duke S-AS, Co­lag­iuri S, Co­lag­iuri R. In­di­vid­u­al pa­tiented­u­ca­tionfor peo­ple withtype 2 di­a­betes mel­li­tus. Cochrane Database Syst Rev 2009;1: CD005268
29. Odgers-‍Jew­ell K, Ball LE, Kelly JT, Isen­ring EA, Rei­dlinger DP, Thomas R. Ef­fec­tive­ness of group­based self-‍man­age­ment ed­u­ca­tion for in­di­vid­u­als with type 2 di­a­betes: a sys­tematic re­view with meta-‍anal­y­ses and meta-‍re­gres­sion. Di­a­bet Med 2017;34:1027–1039
30. Pereira K, Phillips B, John­son C, Vorder­strasse A. In­ternet de­liv­ered di­a­betes self-‍man­age­ment ed­u­ca­tion: a re­view. Di­a­betes Tech­nol Ther 2015;17:55–63
31. Sepah SC, Jiang L, Pe­ters AL. Long-‍term out­comes of a Web-‍based di­a­betes pre­ven­tion pro­gram: 2-year re­sults of a sin­gle-‍arm lon­gi­tu­di­nal study. J Med In­ternet Res 2015;17:e92
32. Green­wood DA, Gee PM, Fatkin KJ, Peeples M. A sys­tematic re­view of re­views eval­u­at­ing tech­nol­o­gy-en­abled di­a­betes self-‍man­age­ment ed­u­ca­tion and sup­port. J Di­a­betes Sci Tech­nol 2017;11:1015–1027
33. van Eiken­horst L, Taxis K, van Dijk L, de Gier H. Pharmacist-‍led self-‍man­age­ment in­ter­ven­tions to im­prove di­a­betes out­comes. A sys­tematic lit­er­a­ture re­view and meta-‍anal­y­sis. Front Phar­ma­col 2017;8:891
34. Tshi­anan­ga JKT, Kocher S, Weber C, Erny-‍Albrecht K, Berndt K, Neeser K. The ef­fect of nurse-‍led di­a­betes self-‍man­age­ment ed­u­ca­tion on gly­co­sy­lat­ed hemoglobin and car­dio­vas­cu­lar risk fac­tors: a meta-‍anal­y­sis. Di­a­betes Educ 2012; 38:108–123
35. Evert AB, Bouch­er JL, Cy­press M, et al. Nu­tri­tion ther­a­py rec­om­men­da­tions for the man­age­ment of adults with di­a­betes. Di­a­betes Care 2014;37(Suppl. 1):S120–S143
36. Shah M, Kaselitz E, Heisler M. The role of com­mu­ni­ty health work­ers in di­a­betes: up­date on cur­rent lit­er­a­ture. Curr Diab Rep 2013;13:163– 171
37. Spencer MS, Ki­ef­fer EC, Sinco B, et al. Out­comes at 18 months from a com­mu­ni­ty health work­er and peer lead­er di­a­betes self-‍man­age­ment pro­gram for Lati­no adults. Di­a­betes Care 2018;41:1414–1422
38. Heisler M, Vijan S, Makki F, Piette JD. Di­a­betes con­trol with re­cip­ro­cal peer sup­port ver­sus nurse care man­age­ment: a ran­dom­ized trial. Ann In­tern Med 2010;153:507–515
39. Long JA, Jahn­le EC, Richard­son DM, Loewen­stein G, Volpp KG. Peer men­tor­ing and finan­cial in­cen­tives to im­prove glu­cose con­trol in African Amer­i­can vet­er­ans: a ran­dom­ized trial. Ann In­tern Med 2012;156:416–424
40. Fish­er EB, Boothroyd RI, El­stad EA, et al. Peer sup­port of com­plex health be­hav­iors in pre­ven­tion and dis­ease man­age­ment with spe­cial ref­er­ence to di­a­betes: sys­tematic re­views. Clin Di­a­betes En­docrinol 2017;3:4
41. Fos­ter G, Tay­lor SJC, El­dridge SE, Ram­say J, Griffiths CJ. Self-‍man­age­ment ed­u­ca­tion pro­grammes by lay lead­ers for peo­ple with chron­ic con­di­tions. Cochrane Database Syst Rev 2007;4: CD005108
42. Dun­can I, Birk­mey­er C, Cough­lin S, Li QE, Sherr D, Boren S. As­sess­ing the value of di­a­betes ed­u­ca­tion. Di­a­betes Educ 2009;35:752–760
43. John­son TM, Mur­ray MR, Huang Y. As­so­ci­a­tions be­tween self-‍man­age­ment ed­u­ca­tion and com­pre­hen­sive di­a­betes clin­i­cal care. Di­a­betes Spec­tr 2010;23:41–46
44. Straw­bridge LM, Lloyd JT, Mead­ow A, Riley GF, How­ell BL. Use of Medi­care’s di­a­betes self-‍man­age­ment train­ing benefit. Health Educ Behav 2015;42:530–538
45. Li R, Shrestha SS, Lip­man R, Bur­rows NR, Kolb LE, Rut­ledge S; Cen­ters for Dis­ease Con­trol and Pre­ven­tion (CDC). Di­a­betes self-‍man­age­ment ed­u­ca­tion and train­ing among pri­vately in­sured per­sons with newly di­ag­nosed di­a­betesdUnited States, 2011–2012. MMWR Morb Mor­tal Wkly Rep 2014;63:1045–1049
46. Hori­g­an G, Davies M, Find­lay-‍White F, Chaney D, Coates V. Rea­sons why pa­tients re­ferred to di­a­betes ed­u­ca­tion pro­grammes choosenot to at­tend: a sys­tematic re­view. Di­a­bet Med 2017;34:14–26
47. Cen­ter For Health Law and Pol­i­cy In­no­va­tion. Recon­sid­ering cost-‍shar­ing for di­a­betes self-‍man­age­ment ed­u­ca­tion: rec­om­men­da­tions for pol­i­cy re­form [In­ternet]. Avail­able from: http:// www.chlpi.org/health_library/recon­sid­ering-cost-‍shar­ing-di­a­betes-self-‍man­age­ment-ed­u­ca­tion-rec­om­men­da­tions-pol­i­cy-re­form/. Ac­cessed 2 Novem­ber 2018
48. Davies MJ, D’Alessio DA, Frad­kin J, et al. Man­age­ment of hy­per­glycemia in type 2 di­a­betes, 2018. A con­sen­sus re­port by the Amer­i­can Di­a­betes As­so­ci­a­tion (ADA) and the Eu­ro­pean As­so­ci­a­tion for the Study of Di­a­betes (EASD). Di­a­betes Care 2018;41:2669–2701
49. Brig­gs Early K, Stan­ley K. Po­si­tion of the Acade­my of Nu­tri­tion and Di­etet­ics: the role of med­i­cal nu­tri­tion ther­a­py and reg­is­tered di­eti­tian nu­tri­tionists in the pre­ven­tion and treat­ment of predi­a­betes and type 2 di­a­betes. J Acad Nutr Diet 2018;118:343–353
50. Franz MJ, MacLeod J, Evert A, et al. Acade­my of Nu­tri­tion and Di­etet­ics nu­tri­tion prac­tice guide­line for type 1 and type 2 di­a­betes in adults: sys­tematic re­view of ev­i­dence for med­i­cal nu­tri­tion ther­a­py ef­fectiveness and rec­om­men­da­tions for in­te­gra­tion into the nu­tri­tion care pro­cess. J Acad Nutr Diet 2017;117:1659–1679
51. MacLeod J, Franz MJ, Handu D, et al. Acade­my of Nu­tri­tion and Di­etet­ics nu­tri­tion prac­tice guide­line for type 1 and type 2 di­a­betes in adults: nu­tri­tion in­ter­ven­tion ev­i­dence re­views and rec­om­men­da­tions. J Acad Nutr Diet 2017;117: 1637–1658
52. Schwing­shackl L, Chaimani A, Hoff­mann G, Schwed­helm C, Boe­ing H. A net­work meta­anal­y­sis on the com­par­a­tive efficacy of dif­fer­ent di­etary ap­proaches on gly­caemic con­trol in pa­tients with type 2 di­a­betes mel­li­tus. Eur J Epi­demi­ol 2018;33:157–170
53. Maryniuk MD. From pyra­mids to plates to pat­terns: per­spec­tives on meal plan­ning. Di­a­betes Spec­tr 2017;30:67–70
54. Schwing­shackl L, Schwed­helm C, Hoff­mann G, et al. Food groups and risk of all-‍cause mor­tal­i­ty: a sys­tematic re­view and meta-‍anal­y­sis of prospec­tive stud­ies. Am J Clin Nutr 2017;105:1462–1473
55. Es­pos­i­to K, Maior­i­no MI, Cioto­la M, et al. Ef­fects of a Mediter­ranean-‍style diet on the need for an­ti­hy­per­glycemic drug ther­a­py in pa­tients with newly di­ag­nosed type 2 di­a­betes: a ran­dom­ized trial. Ann In­tern Med 2009;151:306–314
56. Bouch­er JL. Mediter­ranean eat­ing pat­tern. Di­a­betes Spec­tr 2017;30:72–76
57. Ce­s­pedes EM, Hu FB, Tin­ker L, et al. Mul­ti­ple health­ful di­etary pat­terns and type 2 di­a­betes in the Women’s Health Ini­tia­tive. Am J Epi­demi­ol 2016;183:622–633
58. Ley SH, Hamdy O, Mohan V, Hu FB. Pre­ven­tion and man­age­ment of type 2 di­a­betes: di­etary com­po­nents and nu­tri­tional strate­gies. Lancet 2014;383:1999–2007
59. Camp­bell AP. DASH eat­ing plan: an eat­ing pat­tern for di­a­betes man­age­ment. Di­a­betes Spec­tr 2017;30:76–81
60. Ri­nal­di S, Camp­bell EE, Fournier J, O’Con­nor C, Madill J. A com­pre­hen­sive re­view of the lit­er­a­ture sup­porting rec­om­men­da­tions from the Cana­di­an Di­a­betes As­so­ci­a­tion for the use of a plant-‍based diet for man­age­ment of type 2 di­a­betes. Can J Di­a­betes 2016;40:471–477
61. Pawlak R. veg­e­tar­i­an diets in the pre­ven­tion and man­age­ment of di­a­betes and its com­pli­ca­tions. Di­a­betes Spec­tr 2017;30:82–88
62. Saslow LR, Dauben­mi­er JJ, Moskowitz JT, et al. Twelve-‍month out­comes of a ran­dom­ized trial of a mod­er­ate-‍car­bo­hy­drate ver­sus very low-‍car­bo­hy­drate diet in over­weight adults with type 2 di­a­betes mel­li­tus or predi­a­betes. Nutr Di­a­betes 2017;7:304
63. Hall­berg SJ, McKen­zie AL, Williams PT, et al. Ef­fec­tive­ness and safe­ty of a novel care model for the man­age­ment of type 2 di­a­betes at 1 year: an open-‍label, non-‍ran­dom­ized, con­trolled study. Di­a­betes Ther 2018;9:583–612
64. Sains­bury E, Kiziri­an NV, Par­tridge SR, Gill T, Co­lag­iuri S, Gib­son AA. Ef­fect of di­etary car­bo­hy­drate re­stric­tion on glycemic con­trol in adults with di­a­betes: a sys­tematic re­view and meta-‍anal­y­sis. Di­a­betes Res Clin Pract 2018;139: 239–252
65. U.S. Food and Drug Ad­min­is­tra­tion. FDA Drug Safe­ty Com­mu­ni­ca­tion: FDA re­vis­es la­bels of SGLT2 in­hibitors for di­a­betes to in­clude warn­ings about too much acid in the blood and se­ri­ous uri­nary tract in­fec­tions [In­ternet], 2015. Avail­able from http://www.fda.gov/Drugs/DrugSafe­ty/ucm475463.htm. Ac­cessed 2 Novem­ber 2018
66. Blau JE, Tella SH, Tay­lor SI, Rother KI. Ke­toaci­do­sis as­so­ci­at­ed with SGLT2 in­hibitor treat­ment: anal­y­sis of FAERS data. Di­a­betes Metab Res Rev 2017;33:e2924
67. Bowen ME, Ca­vanaugh KL, Wolff K, et al. The di­a­betes nu­tri­tion ed­u­ca­tion study ran­dom­ized con­trolled trial: a com­par­a­tive ef­fectiveness study of ap­proaches to nu­tri­tion in di­a­betes self-‍man­age­ment ed­u­ca­tion. Pa­tient Educ Couns 2016;99:1368–1376
68. Mu­daliar U, Za­betian A, Good­man M, et al. Cardiometabol­ic risk fac­tor changes ob­served in di­a­betes pre­ven­tion pro­grams in US set­tings: a sys­tematic re­view and meta-‍anal­y­sis. PLoS Med 2016;13:e1002095
69. Balk EM, Ear­ley A, Raman G, Aven­dano EA, Pit­tas AG, Rem­ing­ton PL. Com­bined diet and phys­i­cal ac­tiv­i­ty promo­tion pro­grams to pre­vent type 2 di­a­betes among per­sons at in­creased risk: a sys­tematic re­view for the Com­mu­ni­ty Pre­ven­tive Ser­vices Task Force. Ann In­tern Med 2015; 163:437–451
70. Franz MJ, Bouch­er JL, Rut­ten-‍Ramos S, Van­Wormer JJ. Lifestyle weight-‍loss in­ter­ven­tion out­comes in over­weight and obese adults with type 2 di­a­betes: a sys­tematic re­view and meta­anal­y­sis of ran­dom­ized clin­i­cal tri­als. J Acad Nutr Diet 2015;115:1447–1463
71. Sum­ithran P, Pren­der­gast LA, Del­bridge E, et al. Long-‍term per­sis­tence of hor­mon­al adap­ta­tions to weight loss. N Engl J Med 2011;365: 1597–1604
72. Hamdy O, Mot­tal­ib A, Morsi A, et al. Long-‍term ef­fect of in­ten­sive lifestyle in­ter­ven­tion on car­dio­vas­cu­lar risk fac­tors in pa­tients with di­a­betes in real-‍world clin­i­cal prac­tice: a 5-year lon­gi­tu­di­nal study. BMJ Open Di­a­betes Res Care 2017;5:e000259
73. Lean ME, Leslie WS, Barnes AC, et al. Pri­ma­ry care-‍led weight man­age­ment for re­mis­sion of type 2 di­a­betes (Di­RECT): an open-‍label, clus­ter­ran­domised trial. Lancet 2018;391:541–551
74. Mot­tal­ib A, Sals­berg V, Mohd-‍Yusof B-N, et al. Ef­fects of nu­tri­tion ther­a­py on HbA1c and car­dio­vas­cu­lar dis­ease risk fac­tors in over­weight and obese pa­tients with type 2 di­a­betes. Nutr J 2018;17:42
75. Es­truch R, Ros E, Salas-‍Salvado´ J, et al.; PRED­IMED Study In­ves­ti­ga­tors. Pri­ma­ry pre­ven­tion of car­dio­vas­cu­lar dis­ease with a Mediter­ranean diet sup­ple­ment­ed with extra-‍virgin olive oil or nuts. N Engl J Med 2018;378:e34
76. Ema­di­an A, An­drews RC, Eng­land CY, Wal­lace V, Thomp­son JL. The ef­fect of macronu­tri­ents on gly­caemic con­trol: a sys­tematic re­view of di­etary ran­domised con­trolled tri­als in over­weight and obese adults with type 2 di­a­betes in which there was no dif­fer­ence in weight loss be­tween treat­ment groups. Br J Nutr 2015;114:1656–1666
77. Gard­ner CD, Trepanows­ki JF, Del Gobbo LC, et al. Ef­fect of low-‍fat vs low-‍car­bo­hy­drate diet on 12-‍month weight loss in over­weight adults and the as­so­ci­a­tion with geno­type pat­tern or in­sulin se­cre­tion: the DI­ET­FITS ran­dom­ized clin­i­cal trial. JAMA 2018;319:667–679
78. Sacks FM, Bray GA, Carey VJ, et al. Com­par­i­son of weight-‍loss diets with dif­fer­ent com­po­si­tions of fat, pro­tein, and car­bo­hy­drates. N Engl J Med 2009;360:859–873
79. de Souza RJ, Bray GA, Carey VJ, et al. Ef­fects of 4 weight-‍loss diets dif­fer­ing in fat, pro­tein, and car­bo­hy­drate on fat mass, lean mass, vis­cer­al adi­pose tis­sue, and hep­at­ic fat: re­sults from the POUNDS LOST trial. Am J Clin Nutr 2012;95:614– 625
80. John­ston BC, Kan­ters S, Ban­dayrel K, et al. Com­par­i­son of weight loss among named diet pro­grams in over­weight and obese adults: a meta-‍anal­y­sis. JAMA 2014;312:923–933
81. Fox CS, Gold­en SH, An­der­son C, et al.; Amer­i­can Heart As­so­ci­a­tion Di­a­betes Com­mit­tee of the Coun­cil on Lifestyle and Cardiometabol­ic Health, Coun­cil on Clin­i­cal Car­di­ol­o­gy, Coun­cil on Car­dio­vas­cu­lar and Stroke Nurs­ing, Coun­cil on Car­dio­vas­cu­lar Surgery and Anes­the­sia, Coun­cil on Qual­i­ty of Care and Out­comes Re­search; Amer­i­can Di­a­betes As­so­ci­a­tion. Up­date on pre­ven­tion of car­dio­vas­cu­lar dis­ease in adults with type 2 di­a­betes mel­li­tus in light of re­cent ev­i­dence: a sci­en­tific state­ment from the Amer­i­can Heart As­so­ci­a­tion and the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2015;38:1777–1803
82. DAFNE Study Group. Train­ing in flex­i­ble, in­ten­sive in­sulin man­age­ment to en­able di­etary free­dom in peo­ple with type 1 di­a­betes: Dose Ad­just­ment for Nor­mal Eat­ing (DAFNE) ran­domised con­trolled trial. BMJ 2002;325:746
83. De­la­han­ty LM, Nathan DM, Lachin JM, et al.; Di­a­betes Con­trol and Com­plications Trial/‍ Epi­demi­ology of Di­a­betes In­ter­ven­tions and Com­plications. As­so­ci­a­tion of diet with gly­cat­ed hemoglobin dur­ing in­ten­sive treat­ment of type 1 di­a­betes in the Di­a­betes Con­trol and Com­plications Trial. Am J Clin Nutr 2009;89:518–524
84. Wheel­er ML, Dun­bar SA, Jaacks LM, et al. Macronu­tri­ents, food groups, and eat­ing pat­terns in the man­age­ment of di­a­betes: a sys­tematic re­view of the lit­er­a­ture, 2010. Di­a­betes Care 2012;35:434–445
85. Thomas D, El­liott EJ. Low gly­caemic index, or low gly­caemic load, diets for di­a­betes mel­li­tus. Cochrane Database Syst Rev 2009;1:CD006296
86. Snor­gaard O, Poulsen GM, An­der­sen HK, As­trup A. Sys­tem­at­ic re­view and meta-‍anal­y­sis of di­etary car­bo­hy­drate re­stric­tion in pa­tients with type 2 di­a­betes. BMJ Open Di­a­betes Res Care 2017;5:e000354
87. van Wyk HJ, Davis RE, Davies JS. A crit­i­cal re­view of low-‍car­bo­hy­drate diets in peo­ple with type 2 di­a­betes. Di­a­bet Med 2016;33:148–157
88. Meng Y, Bai H, Wang S, Li Z, Wang Q, Chen L. Efficacy of low car­bo­hy­drate diet for type 2 di­a­betes mel­li­tus man­age­ment: a sys­tematic re­view and meta-‍anal­y­sis ofran­dom­ized con­trolled tri­als. Di­a­betes Res Clin Pract 2017;131:124–131
89. Tay J, Luscombe-‍Marsh ND, Thomp­son CH, et al. Com­par­i­son of low- and high-‍car­bo­hy­drate diets for type 2 di­a­betes man­age­ment: a ran­dom­ized trial. Am J Clin Nutr 2015;102:780–790
90. U.S. De­part­ment of Agricul­ture and U.S. De­part­ment of Health and Human Ser­vices. Di­etary guide­lines for Amer­i­cans 2015-2020, Eighth Edi­tion [In­ternet], 2015. Avail­able from https:/‍/‍health.gov/di­etaryguide­lines/2015/guide­lines. Ac­cessed 2 Novem­ber 2018
91. Nansel TR, Lip­sky LM, Liu A. Greater diet qual­i­ty is as­so­ci­at­ed with more op­ti­mal glycemic con­trol in a lon­gi­tu­di­nal study of youth with type 1 di­a­betes. Am J Clin Nutr 2016;104:81–87
92. Katz ML, Mehta S, Nansel T, Quinn H, Lip­sky LM, Laf­fel LMB. As­so­ci­a­tions of nu­tri­ent in­take with glycemic con­trol in youth with type 1 di­a­betes: dif­fer­ences by in­sulin reg­i­men. Di­a­betes Tech­nol Ther 2014;16:512–518
93. Rossi MCE, Nicoluc­ci A, Di Bar­to­lo P, et al. Di­a­betes Interac­tive Diary: a new telemedicine sys­tem en­abling flex­i­ble diet and in­sulin ther­a­py while im­prov­ing qual­i­ty of life: an open-‍label, interna­tion­al, multicen­ter, ran­dom­ized study. Di­a­betes Care 2010;33:109– 115
94. Lau­ren­zi A, Bolla AM, Panigo­ni G, et al. Ef­fects of car­bo­hy­drate count­ing on glu­cose con­trol and qual­i­ty of life over 24 weeks in adult pa­tients with type 1 di­a­betes on con­tin­u­ous sub­cu­ta­neous in­sulin in­fu­sion: a ran­dom­ized, prospec­tive clin­i­cal trial (GIO­CAR). Di­a­betes Care 2011;34:823–827
95. Sa¨mann A, Mu¨hlhaus­er I, Ben­der R, Kloos Ch, Mu¨ller UA. Gly­caemic con­trol and se­vere hy­po­gly­caemia fol­lowing train­ing in flex­i­ble, in­ten­sive in­sulin ther­a­py to en­able di­etary free­dom in peo­ple with type 1 di­a­betes: a prospec­tive im­ple­mentation study. Di­a­betologia 2005;48: 1965–1970
96. Bell KJ, Bar­clay AW, Petocz P, Co­lag­iuri S, Brand-‍Miller JC. Efficacy of car­bo­hy­drate count­ing in type 1 di­a­betes: a sys­tematic re­view and meta-‍anal­y­sis. Lancet Di­a­betes En­docrinol 2014; 2:133–140
97. Bell KJ, Smart CE, Steil GM, Brand-‍Miller JC, King B, Wolpert HA. Im­pact of fat, pro­tein, and glycemic index on post­pran­di­al glu­cose con­trol in type 1 di­a­betes: im­pli­ca­tions for in­ten­sive di­a­betes man­age­ment in the con­tin­u­ous glu­cose mon­i­tor­ing era. Di­a­betes Care 2015;38:1008– 1015
98. Bell KJ, Toschi E, Steil GM, Wolpert HA. Op­ti­mized meal­time in­sulin dos­ing for fat and pro­teinin type 1 di­a­betes: applicationofamodel-‍based ap­proach to de­rive in­sulin doses for open-‍loop di­a­betes man­age­ment. Di­a­betes Care 2016; 39:1631–1634
99. Pa­ter­son MA, Smart CEM, Lopez PE, et al. Influence of di­etary pro­tein on post­pran­di­al blood glu­cose lev­els in in­di­vid­u­als with type 1 di­a­betes mel­li­tus using in­ten­sive in­sulin ther­a­py. Di­a­bet Med 2016;33:592–598
100. Tut­tle KR, Bakris GL, Bilous RW, et al. Di­a­bet­ic kid­ney dis­ease: a re­port from an ADA Con­sen­sus Con­fer­ence. Di­a­betes Care 2014;37: 2864–2883
101. Pan Y, Guo LL, Jin HM. Low-‍pro­tein diet for di­a­bet­ic nephropa­thy: a meta-‍anal­y­sis of ran­dom­ized con­trolled tri­als. Am J Clin Nutr 2008; 88:660–666
102. Robert­son L, Waugh N, Robert­son A. Pro­tein re­stric­tion for di­a­bet­ic renal dis­ease. Cochrane Database Syst Rev 2007;4:CD002181
103. Lay­man DK, Clifton P, Gan­non MC, Krauss RM, Nut­tall FQ. Pro­tein in op­ti­mal health: heart dis­ease and type 2 di­a­betes. Am J Clin Nutr 2008; 87:1571S–1575S
104. In­sti­tute of Medicine. Di­etary ref­er­ence in­takes for en­er­gy, car­bo­hy­drate, fiber, fat, fatty acids, choles­terol, pro­tein, and amino acids [In­ternet], 2005. Wash­ing­ton, DC, Na­tion­al Academies Press. Avail­able from http:// www.na­tion­alacademies.org/‍hmd/‍Re­ports/‍ 2002/Di­etary-Reference-Intakes-for-Energy-Carbohydrate-Fiber-Fat-Fatty-Acids-Cholesterol-Pro­tein-and-Amino-Acids.aspx Ac­cessed 2 Novem­ber 2018
105. Ros E. Di­etary cis-monounsat­u­rat­ed fatty acids and metabol­ic con­trol in type 2 di­a­betes. Am J Clin Nutr 2003;78(Suppl.):617S–625S
106. Forouhi NG, Ima­mu­ra F, Sharp SJ, et al. As­so­ci­a­tion of plas­ma phos­pho­lipid n-3 and n-6 polyunsat­u­rat­ed fatty acids with type 2 di­a­betes: the EPIC-‍InterAct case-‍co­hort study. PLoS Med 2016;13:e1002094
107. Wang DD, Li Y, Chi­uve SE, et al. As­so­ci­a­tion of specific di­etary fats with total and caus­especific mor­tal­i­ty. JAMA In­tern Med 2016;176: 1134–1145
108. Brehm BJ, Lat­tin BL, Sum­mer SS, et al. One-‍year com­par­i­son of a high–monounsat­u­rat­ed fat diet with a high-‍car­bo­hy­drate diet in type 2 di­a­betes. Di­a­betes Care 2009;32:215–220
109. Shai I, Schwarz­fuchs D, Henkin Y, et al.; Di­etary In­ter­ven­tion Ran­dom­ized Con­trolled Trial (Di­RECT) Group. Weight loss with a lowcar­bo­hy­drate, Mediter­ranean, or low-‍fat diet. N Engl J Med 2008;359:229–241
110. Brunero­va L, Sme­jkalo­va V, Po­tock­o­va J, Andel M. A com­par­i­son of the influence of a high-‍fat diet en­riched in monounsat­u­rat­ed fatty acids and con­ven­tion­al diet on weight loss and metabol­ic pa­ram­e­ters in obese non-‍di­a­bet­ic and type 2 di­a­bet­ic pa­tients. Di­a­bet Med 2007;24: 533–540
111. Bloomfield HE, Koeller E, Greer N, Mac­Don­ald R, Kane R, Wilt TJ. Ef­fects on health out­comes of a Mediter­ranean diet with no re­stric­tion on fat in­take: a sys­tematic re­view and meta-‍anal­y­sis. Ann In­tern Med 2016;165:491– 500
112. Sacks FM, Licht­en­stein AH, Wu JHY, et al.; Amer­i­can Heart As­so­ci­a­tion. Di­etary fats and car­dio­vas­cu­lar dis­ease: a presiden­tial ad­vi­so­ry from the Amer­i­can Heart As­so­ci­a­tion. Cir­cu­la­tion 2017;136:e1–e23
113. Ja­cob­son TA, Maki KC, Or­ringer CE, et al.; NLA Ex­pert Panel. Na­tion­al Lipid As­so­ci­a­tion rec­om­men­da­tions for pa­tient-‍cen­tered man­age­ment of dys­lipi­demia: part 2. J Clin Lipi­dol 2015;9 (Suppl.):S1–S122.e1
114. Har­ris WS, Mozaf­far­i­an D, Rimm E, et al. Omega-‍6 fatty acids and risk for car­dio­vas­cu­lar dis­ease: a sci­ence ad­vi­so­ry from the Amer­i­can Heart As­so­ci­a­tion Nu­tri­tion Subcom­mit­tee of the Coun­cil on Nu­tri­tion, Phys­i­cal Ac­tiv­i­ty, and Metabolism; Coun­cil on Car­dio­vas­cu­lar Nurs­ing; and Coun­cil on Epi­demi­ology and Pre­ven­tion. Cir­cu­la­tion 2009;119:902–907
115. Crochemore ICC, Souza AFP, de Souza ACF, Rosa­do EL. v-3 polyunsat­u­rat­ed fatty acid sup­ple­men­ta­tion does not influence body com­po­si­tion, in­sulin re­sis­tance, and lipemia in women with type 2 di­a­betes and obe­si­ty. Nutr Clin Pract 2012;27:553–560
116. Hol­man RR, Paul S, Farmer A, Tuck­er L, Strat­ton IM, Neil HA; Ator­vas­tatin in Fac­to­ri­al with Omega-‍3 EE90 Risk Re­duc­tion in Di­a­betes Study Group. Ator­vas­tatin in Fac­to­ri­al with Omega-‍3 EE90 Risk Re­duc­tion in Di­a­betes (AFOR­RD): a ran­domised con­trolled trial. Di­a­betologia 2009;52:50–59
117. Kromhout D, Gelei­jnse JM, de Goede J, et al. n-3 fatty acids, ven­tric­u­lar arrhythmia-re­lat­ed events, and fatal my­ocar­dial in­farc­tion in post-‍my­ocar­dial in­farc­tion pa­tients with di­a­betes. Di­a­betes Care 2011;34:2515–2520
118. Bosch J, Ger­stein HC, Da­ge­nais GR, et al.; ORI­GIN Trial In­ves­ti­ga­tors. n-3 fatty acids and car­dio­vas­cu­lar out­comes in pa­tients with dys­g­lycemia. N Engl J Med 2012;367:309–318
119. Thomas MC, Moran J, Fors­blom C, et al.; FinnDi­ane Study Group. The as­so­ci­a­tion be­tween di­etary sodi­um in­take, ESRD, and all-‍cause mor­tal­i­ty in pa­tients with type 1 di­a­betes. Di­a­betes Care 2011;34:861–866
120. Ek­in­ci EI, Clarke S, Thomas MC, et al. Di­etary salt in­take and mor­tal­i­ty in pa­tients with type 2 di­a­betes. Di­a­betes Care 2011;34:703–709
121. Lennon SL, DellaValle DM, Rod­der SG, et al. 2015 Ev­i­dence Anal­y­sis Li­brary ev­i­dence-‍based nu­tri­tion prac­tice guide­line for the man­age­ment of hy­per­ten­sion in adults. J Acad Nutr Diet 2017; 117:1445–1458.e17
122. Mail­lot M, Drewnows­ki A. A conflict be­tween nu­tri­tionally ad­e­quate diets and meet­ing the 2010 di­etary guide­lines for sodi­um. Am J Prev Med 2012;42:174–179
123. Aroda VR, Edel­stein SL, Gold­berg RB, et al.; Di­a­betes Pre­ven­tion Pro­gram Re­search Group. Long-‍term met­formin use and vi­ta­min B12 deficien­cy in the Di­a­betes Pre­ven­tion Pro­gram Out­comes Study. J Clin En­docrinol Metab 2016;101:1754–1761
124. Allen RW, Schwartz­man E, Baker WL, Cole­man CI, Phung OJ. Cin­na­mon use in type 2 di­a­betes: an up­dated sys­tematic re­view and meta-‍anal­y­sis. Ann Fam Med 2013;11:452–459
125. Mitri J, Pit­tas AG. Vi­ta­min D and di­a­betes. En­docrinol Metab Clin North Am 2014;43: 205–232
126. Mozaf­far­i­an D. Di­etary and pol­i­cy pri­or­i­ties for car­dio­vas­cu­lar dis­ease, di­a­betes, and obe­si­ty: a com­pre­hen­sive re­view. Cir­cu­la­tion 2016;133: 187–225
127. Grotz VL, Pi-‍Sunyer X, Porte D Jr, Roberts A, Richard Trout J. A 12-week ran­dom­ized clin­i­cal trial in­ves­ti­gat­ing the po­ten­tial for su­cralose to af­fect glu­cose home­osta­sis. Regul Tox­i­col Phar­ma­col 2017;88:22–33
128. Miller PE, Perez V. Low-‍calo­rie sweet­en­ers and body weight and com­po­si­tion: a meta­anal­y­sis of ran­dom­ized con­trolled tri­als and prospec­tive co­hort stud­ies. Am J Clin Nutr 2014;100:765–777
129. Rogers PJ, Hogenkamp PS, de Graaf C, et al. Does low-‍en­er­gy sweet­en­er con­sump­tion af­fect en­er­gy in­take and body weight? A sys­tematic re­view, in­clud­ing meta-‍anal­y­ses, of the ev­i­dence from human and an­i­mal stud­ies. Int J Obes 2016; 40:381–394
130. Azad MB, Abou-‍Setta AM, Chauhan BF, et al. Non­nu­tri­tive sweet­en­ers and cardiometabol­ic health: a sys­tematic re­view and meta­anal­y­sis of ran­dom­ized con­trolled tri­als and prospec­tive co­hort stud­ies. CMAJ 2017;189: E929–E939
131. Eckel RH, Ja­ki­cic JM, Ard JD, et al. 2013 AHA/ ACC guide­line on lifestyle man­age­ment to re­duce car­dio­vas­cu­lar risk: a re­port of the Amer­i­can Col­lege of Car­di­ol­o­gy/Amer­i­can Heart As­so­ci­a­tion Task Force on Prac­tice Guide­lines. Cir­cu­la­tion 2013;129(Suppl.):S76–S99
132. John­son RK, Licht­en­stein AH, An­der­son CAM, et al.; Amer­i­can Heart As­so­ci­a­tion Nu­tri­tion Com­mit­tee of the Coun­cil on Lifestyle and Cardiometabol­ic Health; Coun­cil on Car­dio­vas­cu­lar and Stroke Nurs­ing; Coun­cil on Clin­i­cal Car­di­ol­o­gy; Coun­cil on Qual­i­ty of Care and Out­comes Re­search; Stroke Coun­cil. Low-‍calo­rie sweet­ened bev­er­ages and cardiometabol­ic health: a sci­ence ad­vi­so­ry from the Amer­i­can Heart As­so­ci­a­tion. Cir­cu­la­tion 2018;138:e126–e140
133. 2018 Phys­i­cal Ac­tiv­i­ty Guide­lines Ad­vi­so­ry Com­mit­tee. 2018 Phys­i­cal Ac­tiv­i­ty Guide­lines Ad­vi­so­ry Com­mit­tee Sci­en­tific Re­port. Wash­ing­ton, DC, U.S. De­part­ment of Health and Human Ser­vices, 2018
134. Bazargan-‍Hejazi S, Ar­royo JS, Hsia S, Bro­jeni NR, Pan D. A racial com­par­i­son of dif­fer­ences be­tween self-‍re­port­ed and ob­jec­tive­ly mea­sured phys­i­cal ac­tiv­i­ty among US adults with di­a­betes. Ethn Dis 2017;27:403–410
135. Sluik D, Bui­jsse B, Muck­el­bauer R, et al. Phys­i­cal ac­tiv­i­ty and mor­tal­i­ty in in­di­vid­u­als with di­a­betes mel­li­tus: a prospec­tive study and meta-‍anal­y­sis. Arch In­tern Med 2012;172:1285– 1295
136. Tikkanen-‍Dolenc H, Wade´n J, Fors­blom C, et al.; FinnDi­ane Study Group. Phys­i­cal ac­tiv­i­ty re­duces risk of pre­ma­ture mor­tal­i­ty in pa­tients with type 1 di­a­betes with and with­out kid­ney dis­ease. Di­a­betes Care 2017;40:1727–1732
137. Boule´ NG, Had­dad E, Kenny GP, Wells GA, Sigal RJ. Ef­fects of ex­er­cise on glycemic con­trol and body mass in type 2 di­a­betes mel­li­tus: a meta-‍anal­y­sis of con­trolled clin­i­cal tri­als. JAMA 2001;286:1218–1227
138. Col­berg SR, Rid­dell MC. Phys­i­cal ac­tiv­i­ty: reg­u­la­tion of glu­cose metabolism, clin­i­cal man­age­ment strate­gies, and weight con­trol. In Amer­i­can Di­a­betes As­so­ci­a­tion/JDRF Type 1 Di­a­betes Source­book. Pe­ters A, Laf­fel L, Eds. Alexan­dria, VA, Amer­i­can Di­a­betes As­so­ci­a­tion, 2013
139. Ost­man C, Jewiss D, King N, Smart NA. Clin­i­cal out­comes to ex­er­cise train­ing in type 1 di­a­betes: a sys­tematic re­view and meta-‍anal­y­sis. Di­a­betes Res Clin Pract 2018;139:380–391
140. Boule´ NG, Kenny GP, Had­dad E, Wells GA, Sigal RJ. Meta-‍anal­y­sis of the ef­fect of struc­tured ex­er­cise train­ing on car­dio­re­spi­rato­ry fitness in type 2 di­a­betes mel­li­tus. Di­a­betologia 2003;46:1071–1081
141. Re­jes­ki WJ, Ip EH, Bertoni AG, et al.; Look AHEAD Re­search Group. Lifestyle change and mo­bil­i­ty in obese adults with type 2 di­a­betes. N Engl J Med 2012;366:1209–1217
142. Col­berg SR, Sigal RJ, Yard­ley JE, et al. Phys­i­cal ac­tiv­i­ty/ex­er­cise and di­a­betes: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2016;39:2065–2079
143. Janssen I, Leblanc AG. Sys­tem­at­ic re­view of the health benefits of phys­i­cal ac­tiv­i­ty and fitness in school-‍aged chil­dren and youth. Int J Behav Nutr Phys Act 2010;7:40
144. Rid­dell MC, Gallen IW, Smart CE, et al. Ex­er­cise man­age­ment in type 1 di­a­betes: a con­sen­sus state­ment. Lancet Di­a­betes En­docrinol 2017;5:377–390
145. An­der­son BJ, Laf­fel LM, Domenger C, et al. Fac­tors as­so­ci­at­ed with di­a­betes-‍specific health-‍re­lat­ed qual­i­ty of life in youth with type 1 di­a­betes: the glob­al TEENs study. Di­a­betes Care 2017;40:1002–1009
146. Jel­ley­man C, Yates T, O’Dono­van G, et al. The ef­fects of high-‍in­ten­si­ty in­ter­val train­ing on glu­cose reg­u­la­tion and in­sulin re­sis­tance: a meta­anal­y­sis. Obes Rev 2015;16:942–961
147. Lit­tle JP, Gillen JB, Per­ci­val ME, et al. Low-‍vol­ume high-‍in­ten­si­ty in­ter­val train­ing re­duces hy­per­glycemia and in­creases mus­cle mi­to­chon­dri­al ca­pac­i­ty in pa­tients with type 2 di­a­betes. J Appl Phys­i­ol (1985) 2011;111:1554–1560
148. U.S. De­part­ment of Health and Human Ser­vices. 2008 phys­i­cal ac­tiv­i­ty guide­lines for Amer­i­cans [In­ternet], 2008. Avail­able from https:/‍/‍health.gov/paguide­lines/guide­lines/default.aspx. Ac­cessed 2 Novem­ber 2018
149. Wil­ley KA, Singh MAF. Bat­tling in­sulin re­sis­tance in el­der­ly obese peo­ple with type 2 di­a­betes: bring on the heavy weights. Di­a­betes Care 2003;26:1580–1588
150. Katz­marzyk PT, Church TS, Craig CL, Bouchard C. Sit­ting time and mor­tal­i­ty from all caus­es, car­dio­vas­cu­lar dis­ease, and can­cer. Med Sci Sports Exerc 2009;41:998–1005
151. Dempsey PC, Larsen RN, Sethi P, et al. Benefits for type 2 di­a­betes of in­ter­rupt­ing pro­longed sit­ting with brief bouts of light walk­ing or sim­ple re­sis­tance ac­tiv­i­ties. Di­a­betes Care 2016;39:964–972
152. Cui J, Yan J-H, Yan L-M, Pan L, Le J-J, Guo Y-Z. Ef­fects of yoga in adults with type 2 di­a­betes mel­li­tus: a meta-‍anal­y­sis. J Di­a­betes In­ves­tig 2017;8:201–209
153. Lee MS, Jun JH, Lim H-J, Lim H-S. A sys­tematic re­view and meta-‍anal­y­sis of tai chi for treat­ing type 2 di­a­betes. Ma­tu­ri­tas 2015;80:14–23
154. Col­berg SR, Sigal RJ, Fern­hall B, et al.; Amer­i­can Col­lege of Sports Medicine; Amer­i­can Di­a­betes As­so­ci­a­tion. Ex­er­cise and type 2 di­a­betes. The Amer­i­can Col­lege of Sports Medicine and the Amer­i­can Di­a­betes As­so­ci­a­tion: joint po­si­tion state­ment ex­ec­u­tive sum­ma­ry. Di­a­betes Care 2010;33:2692–2696
155. Church TS, Blair SN, Cocre­ham S, et al. Ef­fects of aer­o­bic and re­sis­tance train­ing on hemoglobin A1c lev­els in pa­tients with type 2 di­a­betes: a ran­dom­ized con­trolled trial. JAMA 2010;304:2253–2262
156. Bax JJ, Young LH, Frye RL, Bonow RO, Stein­berg HO, Bar­rett EJ; ADA. Screen­ing for coro­nary artery dis­ease in pa­tients with di­a­betes. Di­a­betes Care 2007;30:2729–2736
157. Pe­ters A, Laf­fel L (Eds.). Amer­i­can Di­a­betes As­so­ci­a­tion/JDRF Type 1 Di­a­betes Source­book. Alexan­dria, VA, Amer­i­can Di­a­betes As­so­ci­a­tion, 2013
158. Col­berg SR. Ex­er­cise and Di­a­betes: A Clin­i­cian's Guide to Pre­scrib­ing Phys­i­cal Ac­tiv­i­ty. Alexan­dria, VA, Amer­i­can Di­a­betes As­so­ci­a­tion, 2013
159. Lemas­ter JW, Reiber GE, Smith DG, Hea­ger­ty PJ, Wal­lace C. Daily weight-‍bear­ing ac­tiv­i­ty does not in­crease the risk of di­a­bet­ic foot ul­cers. Med Sci Sports Exerc 2003;35:1093–1099
160. Smith AG, Rus­sell J, Feld­man EL, et al. Lifestyle in­ter­ven­tion for pre-‍di­a­bet­ic neu­ropa­thy. Di­a­betes Care 2006;29:1294–1299
161. Spal­lone V, Ziegler D, Free­man R, et al.; Toron­to Con­sen­sus Panel on Di­a­bet­ic Neu­ropa­thy. Car­dio­vas­cu­lar au­to­nom­ic neu­ropa­thy in di­a­betes: clin­i­cal im­pact, as­sess­ment, di­ag­no­sis, and man­age­ment. Di­a­betes Metab Res Rev 2011;27:639–653
162. Pop-‍Busui R, Evans GW, Ger­stein HC, et al.; Ac­tion to Con­trol Car­dio­vas­cu­lar Risk in Di­a­betes Study Group. Ef­fects of car­diac au­to­nom­ic dys­func­tion on mor­tal­i­ty risk in the Ac­tion to Con­trol Car­dio­vas­cu­lar Risk in Di­a­betes (AC­CORD) trial. Di­a­betes Care 2010;33:1578–1584
163. Suarez L, Bar­rett-‍Con­nor E. In­ter­ac­tion be­tween cigarette smok­ing and di­a­betes mel­li­tus in the pre­dic­tion of death at­tribut­ed to car­dio­vas­cu­lar dis­ease. Am J Epi­demi­ol 1984;120:670– 675
164. Stan­ton CA, Keith DR, Gaale­ma DE, et al. Trends in to­bac­co use among US adults with chron­ic health con­di­tions: Na­tion­al Sur­vey on Drug Use and Health 2005–2013. Prev Med 2016; 92:160–168
165. Bae J. Dif­fer­ences in cigarette use be­hav­iors by age at the time of di­ag­no­sis with di­a­betes from young adult­hood to adult­hood: re­sults from the Na­tion­al Lon­gi­tu­di­nal Study of Ado­les­cent Health. J Prev Med Pub­lic Health 2013;46: 249–260
166. Sli­win´ska-‍Mosson´ M, Mil­nerow­icz H. The im­pact of smok­ing on the de­vel­opment of di­a­betes and its com­pli­ca­tions. Diab Vasc Dis Res 2017;14:265–276
167. Kar D, Gillies C, Za­c­car­di F, et al. Re­la­tion­ship of cardiometabol­ic pa­ram­e­ters in non-‍smok­ers, cur­rent smok­ers, and quit­ters in di­a­betes: a sys­tematic re­view and meta-‍anal­y­sis. Car­dio­vasc Di­a­betol 2016;15:158
168. Jankowich M, Choud­hary G, Taveira TH, Wu W-C. Age-, race-, and gen­der-‍specific preva­lence of di­a­betes among smok­ers. Di­a­betes Res Clin Pract 2011;93:e101–e105
169. Akter S, Goto A, Mi­zoue T. Smok­ing and the risk of type 2 di­a­betes in Japan: a sys­tematic re­view and meta-‍anal­y­sis. J Epi­demi­ol 2017;27: 553–561
170. Liu X, Bragg F, Yang L, et al.; China Kadoorie Biobank Col­lab­o­ra­tive Group. Smok­ing and smok­ing ces­sa­tion in re­la­tion to risk of di­a­betes in Chi­nese men and women: a 9-year prospec­tive study of 0.5 mil­lion peo­ple. Lancet Pub­lic Health 2018;3:e167–e176
171. Yeh HC, Dun­can BB, Schmidt MI, Wang NY, Bran­cati FL. Smok­ing, smok­ing ces­sa­tion, and risk for type 2 di­a­betes mel­li­tus: a co­hort study. Ann In­tern Med 2010;152:10–17
172. Ton­stad S, Lawrence D. Vareni­cline in smok­ers with di­a­betes: a pooled anal­y­sis of 15 ran­dom­ized, placebo-con­trolled stud­ies of vareni­cline. J Di­a­betes In­ves­tig 2017;8:93– 100
173. West R. To­bac­co smok­ing: health im­pact, preva­lence, cor­re­lates and in­ter­ven­tions. Psy­chol Health 2017;32:1018–1036
174. Ran­ney L, Melvin C, Lux L, Mc­Clain E, Lohr KN. Sys­tem­at­ic re­view: smok­ing ces­sa­tion in­ter­ven­tion strate­gies for adults and adults in spe­cial pop­u­la­tions. Ann In­tern Med 2006;145: 845–856
175. Tian J, Venn A, Ota­hal P, Gall S. The as­so­ci­a­tion be­tween quit­ting smok­ing and weight gain: a sys­tematic re­view and meta­anal­y­sis of prospec­tive co­hort stud­ies. Obes Rev 2015;16:883–901
176. Clair C, Rig­ot­ti NA, Porneala B, et al. As­so­ci­a­tion of smok­ing ces­sa­tion and weight change with car­dio­vas­cu­lar dis­ease among adults with and with­out di­a­betes. JAMA 2013;309:1014– 1021
177. Voul­gari C, Kat­sil­am­bros N, Ten­tolouris N. Smok­ing ces­sa­tion pre­dicts ame­lio­ra­tion of microal­bu­min­uria in newly di­ag­nosed type 2 di­a­betes mel­li­tus: a 1-year prospec­tive study. Metabolism 2011;60:1456–1464
178. Huer­ta TR, Walk­er DM, Mullen D, John­son TJ, Ford EW. Trends in e-‍cigarette aware­ness and per­ceived harm­fulness in the U.S. Am J Prev Med 2017;52:339–346
179. Pericot-‍Valverde I, Gaale­ma DE, Priest JS, Hig­gins ST. E-‍cigarette aware­ness, per­ceived harm­fulness, and ever use among U.S. adults. Prev Med 2017;104:92–99
180. Lev­en­thal AM, Strong DR, Kirk­patrick MG, et al. As­so­ci­a­tion of elec­tron­ic cigarette use with ini­ti­a­tion of com­bustible to­bac­co prod­uct smok­ing in early ado­les­cence. JAMA 2015;314:700– 707
181. Lev­en­thal AM, Stone MD, An­dra­bi N, et al. As­so­ci­a­tion of e-‍cigarette va­p­ing and pro­gres­sion to heav­ier pat­terns of cigarette smok­ing. JAMA 2016;316:1918–1920
182. Hart­mann-‍Boyce J, McRob­bie H, Bullen C, Begh R, Stead LF, Hajek P. Elec­tron­ic cigarettes for smok­ing ces­sa­tion. Cochrane Database Syst Rev 2016;9:CD010216
183. Halpern SD, Harhay MO, Sauls­giv­er K, Bro­phy C, Trox­el AB, Volpp KG. A prag­mat­ic trial of e-‍cigarettes, in­cen­tives, and drugs for smok­ing ces­sa­tion. N Engl J Med 2018;378:2302–2310
184. Schrauf­nagel DE, Blasi F, Drum­mond MB, et al.; Forum of In­terna­tion­al Res­pi­ra­to­ry So­ci­eties. Elec­tron­ic cigarettes. A po­si­tion state­ment of the Forum of In­terna­tion­al Res­pi­ra­to­ry So­ci­eties. Am J Respir Crit Care Med 2014;190:611– 618
185. Bam TS, Bellew W, Berezh­no­va I, et al.; To­bac­co Con­trol De­part­ment In­terna­tion­al Union Against Tu­ber­cu­lo­sis and Lung Dis­ease. Po­si­tion state­ment on elec­tron­ic cigarettes or elec­tron­ic nico­tine de­liv­ery sys­tems. Int J Tu­berc Lung Dis 2014;18:5–7
186. Bhat­na­gar A, Whit­sel LP, Ribisl KM, et al.; Amer­i­can Heart As­so­ci­a­tion Ad­vo­ca­cy Co­or­di­nat­ing Com­mit­tee, Coun­cil on Car­dio­vas­cu­lar and Stroke Nurs­ing, Coun­cil on Clin­i­cal Car­di­ol­o­gy, and Coun­cil on Qual­i­ty of Care and Out­comes Re­search. Elec­tron­ic cigarettes: a pol­i­cy state­ment from the Amer­i­can Heart As­so­ci­a­tion. Cir­cu­la­tion 2014;130:1418–1436
187. Young-‍Hyman D, de Groot M, Hill-‍Brig­gs F, Gon­za­lez JS, Hood K, Pey­rot M. Psychoso­cial care for peo­ple with di­a­betes: a po­si­tion state­ment of the Amer­i­can Di­a­betes As­so­ci­a­tion. Di­a­betes Care 2016;39:2126–2140
188. An­der­son RJ, Grigs­by AB, Freed­land KE, et al. Anx­i­ety and poor glycemic con­trol: a meta-‍an­a­lyt­ic re­view of the lit­er­a­ture. Int J Psy­chi­a­try Med 2002;32:235–247
189. De­la­han­ty LM, Grant RW, Wit­ten­berg E, et al. As­so­ci­a­tion of di­a­betes-‍re­lat­ed emo­tion­al dis­tress with di­a­betes treat­ment in pri­ma­ry care pa­tients with type 2 di­a­betes. Di­a­bet Med 2007; 24:48–54
190. An­der­son RJ, Freed­land KE, Clouse RE, Lust­man PJ. The preva­lence of co­mor­bid de­pres­sion in adults with di­a­betes: a meta-‍anal­y­sis. Di­a­betes Care 2001;24:1069–1078
191. Ko­vacs Burns K, Nicoluc­ci A, Holt RIG, et al.; DAWN2 Study Group. Di­a­betes At­ti­tudes, Wish­es and Needs sec­ond study (DAWN2™): crossna­tion­al bench­mark­ing in­di­ca­tors for fam­i­ly mem­bers liv­ing with peo­ple with di­a­betes. Di­a­bet Med 2013;30:778–788
192. Hark­ness E, Mac­don­ald W, Valderas J, Coven­try P, Gask L, Bower P. Iden­ti­fy­ing psy­choso­cial in­ter­ven­tions that im­prove both phys­i­cal and men­tal health in pa­tients with di­a­betes: a sys­tematic re­view and meta-‍anal­y­sis. Di­a­betes Care 2010;33:926–930
193. Nicoluc­ci A, Ko­vacs Burns K, Holt RIG, et al.; DAWN2 Study Group. Di­a­betes At­ti­tudes, Wish­es and Needs sec­ond study (DAWN2™): cross-‍na­tion­al bench­mark­ing of di­a­betes-‍re­lat­ed psy­choso­cial out­comes for peo­ple with di­a­betes. Di­a­bet Med 2013;30:767–777
194. Fish­er L, Hessler DM, Polon­sky WH, Mul­lan J. When is di­a­betes dis­tress clin­i­cally mean­ing­ful?: es­tab­lish­ing cut points for the Di­a­betes Dis­tress Scale. Di­a­betes Care 2012;35:259–264
195. Fish­er L, Glas­gow RE, Stryck­er LA. The re­la­tion­ship be­tween di­a­betes dis­tress and clin­i­cal de­pres­sion with glycemic con­trol among pa­tients with type 2 di­a­betes. Di­a­betes Care 2010;33:1034–1036
196. Aikens JE. Prospec­tive as­so­ci­a­tions be­tween emo­tion­al dis­tress and poor out­comes in type 2 di­a­betes. Di­a­betes Care 2012;35:2472– 2478
197. Fish­er L, Skaff MM, Mul­lan JT, et al. Clin­i­cal de­pres­sion ver­sus dis­tress among pa­tients with type 2 di­a­betes: not just a ques­tion of se­man­tics. Di­a­betes Care 2007;30:542–548
198. Snoek FJ, Brem­mer MA, Her­manns N. Con­structs of de­pres­sion and dis­tress in di­a­betes: time for an ap­praisal. Lancet Di­a­betes En­docrinol 2015;3:450–460
199. Gary TL, Saf­ford MM, Ger­zoff RB, et al. Per­cep­tion of neigh­bor­hood prob­lems, health be­hav­iors, and di­a­betes out­comes among adults with di­a­betes in man­aged care: the Trans­lat­ing Re­search Into Ac­tion for Di­a­betes (TRIAD) study. Di­a­betes Care 2008;31:273– 278
200. Be­ver­ly EA, Hult­gren BA, Brooks KM, Ritholz MD, Abra­ham­son MJ, Weinger K. Understand­ing physi­cians’ chal­lenges when treat­ing type 2 di­a­bet­ic pa­tients’ so­cial and emo­tion­al difficul­ties: a qual­i­ta­tive study. Di­a­betes Care 2011;34:1086–1088
201. Huang Y, Wei X, Wu T, Chen R, Guo A. Col­lab­o­ra­tive care for pa­tients with de­pres­sion and di­a­betes mel­li­tus: a sys­tematic re­view and meta-‍anal­y­sis. BMC Psy­chi­a­try 2013;13: 260